Harvard Radcliffe Institute’s Schlesinger Library to Receive Dr. Susan M. Love’s Intellectual Properties Collection
The Arthur and Elizabeth Schlesinger Library on the History of Women in America in Cambridge, Massachusetts, holds the largest collection of papers by important women in the United States. The Library will receive the life’s work of papers and articles by renowned…
Hovione acquires ExtremoChem and its portfolio of proprietary sugars to support customers with stabilization and delivery of biopharmaceuticals
Hovione, the specialist integrated CDMO and the leader in spray drying and particle engineering, today announced it has acquired ExtremoChem Lda (ExtremoChem), an innovative start-up company focused on the synthesis, development, and commercialization of bio-inspired synthetic sugars, targeting enhanced stabilization,…
USR Holdings Opens Mental Health Center in Treasure Coast Florida
Onyx Behavioral Health is pleased to announce the recent opening of the new private mental health treatment center facility as the first of its kind in the Treasure Coast area and is accepting new patients. Onyx Behavioral Health’s mission is…
Lunit Nets FDA Nod for AI-Powered 3D Breast Tomosynthesis Solution, Lunit INSIGHT DBT
Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its 3D Breast Tomosynthesis (DBT) AI solution, Lunit INSIGHT DBT. This approval…
Transposon Announces Interim Results from a Phase 2 Study of TPN-101 for the Treatment of Progressive Supranuclear Palsy to be Presented at the AD/PD™ 2024 International Conference on Alzheimer’s and Parkinson’s Diseases
Transposon Therapeutics, a biotechnology company developing a platform of novel, orally administered therapies for the treatment of neurodegenerative and aging-related diseases, today announced its abstract of interim results from its Phase 2 study of TPN-101 for the treatment of progressive…
Halozyme and Acumen Pharmaceuticals Enter Global Collaboration and Non-Exclusive License Agreement for the ENHANZE® Technology in Alzheimer’s Disease
Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced a global collaboration and non-exclusive license agreement with Acumen Pharmaceuticals that provides Acumen access to Halozyme’s ENHANZE® drug delivery technology, a proprietary recombinant human hyaluronidase PH20 enzyme (rHuPH20) for rapid subcutaneous drug delivery, for a…
Surgical Information Sciences Initiates VISION Study to Support Deep Brain Stimulation for Parkinson’s Disease Patients
Surgical Information Sciences, a medical device company focused on improved visualization of brain structures for deep brain stimulation (DBS) surgery, announced the commencement of its post-market study, the Visualization of the STN and GPi for DBS Surgery in Patients with…
Sibel Health Announces the Launch of a Powerful Physiological Monitoring Platform for Clinical Trials and New Strategic Collaborations
Sibel Health, an award-winning digital health company, announces the release of Discovery – a powerful physiological monitoring platform designed specifically for clinical trials. The Discovery platform is a turnkey technology solution with FDA-cleared advanced wearable sensors for continuous vital signs…
The Inner Circle Acknowledges, , Lawrence J. Singerman as a Most Trusted Healthcare Professional for his contributions to the Field of Ophthalmology
The Inner Circle Acknowledges, , Lawrence J. Singerman as a Most Trusted Healthcare Professional for his contributions to the Field of Ophthalmology. Dr. Singerman earned a Bachelor of Science degree in Psychology from Case Western Reserve University, and a Medical Degree…
Piramal Pharma Solutions Launches In-Vitro Biology Capabilities at Ahmedabad Discovery Services Site
Piramal Pharma Limited’s Pharma Solutions (PPS) business, a leading Contract Development and Manufacturing Organization (CDMO), today formally announced the launch of a world-class high-throughput screening facility that augments the existing in-vitro biology capabilities at its drug discovery services site in…
